Trial intelligence / Profile preview

Nociceptive and antinociceptive mechanisms under anesthesia using fMRI, EEG and noxious reflexes

2009-016907-41Phase 4Completed

Sponsor
Charité – Universitätsmedizin Berlin
Start
Aug 2012
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of propofol and remifentanil, sponsored by Charité – Universitätsmedizin Berlin. Primary endpoints: Dose dependency of BOLD responses after noxious stimulation under propofol and remifentanil and Changes in nociceptive structures measured by fMRI, EEG, and nociceptive reflexes. Started Aug 2012; status: completed.

02

Drugs

propofolremifentanil

Beyond the preview

Go deeper on 2009-016907-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-016907-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call